Literature DB >> 33716997

Genomic Characterization of Two Shiga Toxin-Converting Bacteriophages Induced From Environmental Shiga Toxin-Producing Escherichia coli.

Yujie Zhang1, Yen-Te Liao1, Alexandra Salvador1, Vivian C H Wu1.   

Abstract

Shiga toxin (Stx), encoded by stx genes located in prophage sequences, is the major agent responsible for the pathogenicity of Shiga toxin-producing Escherichia coli (STEC) and is closely associated with the development of hemolytic uremic syndrome (HUS). Although numerous Stx prophage sequences have been reported as part of STEC bacterial genomes, the information about the genomic characterization of Stx-converting bacteriophages induced from STEC strains is relatively scarce. The objectives of this study were to genomically characterize two Stx-converting phages induced from environmental STEC strains and to evaluate their correlations with published Stx-converting phages and STEC strains of different origins. The Stx1-converting phage Lys8385Vzw and the Stx2-converting phage Lys19259Vzw were induced from E. coli O103:H11 (RM8385) and E. coli O157:H7 (RM19259), respectively. Whole-genome sequencing of these phages was conducted on a MiSeq sequencer for genomic characterization. Phylogenetic analysis and comparative genomics were performed to determine the correlations between these two Stx-converting phages, 13 reference Stx-converting phages, and 10 reference STEC genomes carrying closely related Stx prophages. Both Stx-converting phages Lys8385Vzw and Lys19259Vzw had double-stranded DNA, with genome sizes of 50,953 and 61,072 bp, respectively. Approximately 40% of the annotated coding DNA sequences with the predicted functions were likely associated with the fitness for both phages and their bacterial hosts. The whole-genome-based phylogenetic analysis of these two Stx-converting phages and 13 reference Stx-converting phages revealed that the 15 Stx-converting phages were divided into three distinct clusters, and those from E. coli O157:H7, in particular, were distributed in each cluster, demonstrating the high genomic diversity of these Stx-converting phages. The genomes of Stx-converting phage Lys8385Vzw and Lys19259Vzw shared a high-nucleotide similarity with the prophage sequences of the selected STEC isolates from the clinical and environmental origin. The findings demonstrate the genomic diversity of Stx-converting phages induced from different STEC strains and provide valuable insights into the dissemination of stx genes among E. coli population via the lysogenization of Stx-converting phages.
Copyright © 2021 Zhang, Liao, Salvador and Wu.

Entities:  

Keywords:  Shiga toxin-producing Escherichia coli; Stx-converting bacteriophages; comparative genomics; genetic diversity; virulence gene transfer

Year:  2021        PMID: 33716997      PMCID: PMC7946995          DOI: 10.3389/fmicb.2021.587696

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  89 in total

Review 1.  Shiga toxins: from structure and mechanism to applications.

Authors:  Yau Sang Chan; Tzi Bun Ng
Journal:  Appl Microbiol Biotechnol       Date:  2015-12-19       Impact factor: 4.813

2.  Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations.

Authors:  Søren Persson; Katharina E P Olsen; Steen Ethelberg; Flemming Scheutz
Journal:  J Clin Microbiol       Date:  2007-04-19       Impact factor: 5.948

3.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

4.  Public Health Investigation of Two Outbreaks of Shiga Toxin-Producing Escherichia coli O157 Associated with Consumption of Watercress.

Authors:  Claire Jenkins; Timothy J Dallman; Naomi Launders; Caroline Willis; Lisa Byrne; Frieda Jorgensen; Mark Eppinger; Goutam K Adak; Heather Aird; Nicola Elviss; Kathie A Grant; Dilys Morgan; Jim McLauchlin
Journal:  Appl Environ Microbiol       Date:  2015-04-03       Impact factor: 4.792

5.  Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.

Authors:  Lorena Rodríguez-Rubio; Diana Gutiérrez; David M Donovan; Beatriz Martínez; Ana Rodríguez; Pilar García
Journal:  Crit Rev Biotechnol       Date:  2015-01-21       Impact factor: 8.429

6.  Taxonomy of prokaryotic viruses: 2016 update from the ICTV bacterial and archaeal viruses subcommittee.

Authors:  Evelien M Adriaenssens; Mart Krupovic; Petar Knezevic; Hans-Wolfgang Ackermann; Jakub Barylski; J Rodney Brister; Martha R C Clokie; Siobain Duffy; Bas E Dutilh; Robert A Edwards; Francois Enault; Ho Bin Jang; Jochen Klumpp; Andrew M Kropinski; Rob Lavigne; Minna M Poranen; David Prangishvili; Janis Rumnieks; Matthew B Sullivan; Johannes Wittmann; Hanna M Oksanen; Annika Gillis; Jens H Kuhn
Journal:  Arch Virol       Date:  2016-12-31       Impact factor: 2.574

7.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.

Authors:  Sudhir Kumar; Glen Stecher; Michael Li; Christina Knyaz; Koichiro Tamura
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

8.  VIBRANT: automated recovery, annotation and curation of microbial viruses, and evaluation of viral community function from genomic sequences.

Authors:  Kristopher Kieft; Zhichao Zhou; Karthik Anantharaman
Journal:  Microbiome       Date:  2020-06-10       Impact factor: 14.650

9.  Global In-Silico Scenario of tRNA Genes and Their Organization in Virus Genomes.

Authors:  Sergio Morgado; Ana Carolina Vicente
Journal:  Viruses       Date:  2019-02-21       Impact factor: 5.048

10.  Immunity profiles of wild-type and recombinant shiga-like toxin-encoding bacteriophages and characterization of novel double lysogens.

Authors:  Heather E Allison; Martin J Sergeant; Chloë E James; Jon R Saunders; Darren L Smith; Richard J Sharp; Trevor S Marks; Alan J McCarthy
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.